Published in Cytotechnology on February 10, 2010
Bioprinting for stem cell research. Trends Biotechnol (2012) 1.46
Magnetic manipulation and spatial patterning of multi-cellular stem cell aggregates. Integr Biol (Camb) (2011) 1.01
Embryonic stem cell bioprinting for uniform and controlled size embryoid body formation. Biomicrofluidics (2011) 0.88
Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1β, TNF-α, and IFN-γ. Stem Cells Dev (2014) 0.86
Bioimaging: An Useful Tool to Monitor Differentiation of Human Embryonic Stem Cells into Chondrocytes. Ann Biomed Eng (2015) 0.79
Functional maintenance of differentiated embryoid bodies in microfluidic systems: a platform for personalized medicine. Stem Cells Transl Med (2015) 0.76
Formation of embryoid bodies using dielectrophoresis. Biomicrofluidics (2012) 0.76
A Systemized Approach to Investigate Ca(2+) Synchronization in Clusters of Human Induced Pluripotent Stem-Cell Derived Cardiomyocytes. Front Cell Dev Biol (2016) 0.75
Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med (2000) 5.83
Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature (1986) 4.73
Reproducible, ultra high-throughput formation of multicellular organization from single cell suspension-derived human embryonic stem cell aggregates. PLoS One (2008) 3.08
Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood (2005) 2.69
Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells (2008) 2.34
Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells (2006) 2.20
Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. J Biosci Bioeng (2007) 2.18
A multiscale model for avascular tumor growth. Biophys J (2005) 2.14
A microwell array system for stem cell culture. Biomaterials (2007) 2.10
Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng (2001) 1.97
Rotary suspension culture enhances the efficiency, yield, and homogeneity of embryoid body differentiation. Stem Cells (2007) 1.90
In vitro assays of angiogenesis for assessment of angiogenic and anti-angiogenic agents. Microvasc Res (2007) 1.71
Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol Prog (2009) 1.61
In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng (2004) 1.59
Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3. Exp Hematol (2008) 1.52
Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation. Stem Cells (2005) 1.51
Homogeneous and organized differentiation within embryoid bodies induced by microsphere-mediated delivery of small molecules. Biomaterials (2009) 1.34
Characterization of embryoid bodies of mouse embryonic stem cells formed under various culture conditions and estimation of differentiation status of such bodies. J Biosci Bioeng (2007) 1.34
Embryonic stem cell-derived embryoid bodies development in collagen gels recapitulates sprouting angiogenesis. Lab Invest (2001) 1.33
Development of a perfusion fed bioreactor for embryonic stem cell-derived cardiomyocyte generation: oxygen-mediated enhancement of cardiomyocyte output. Biotechnol Bioeng (2005) 1.28
Embryoid body morphology influences diffusive transport of inductive biochemicals: a strategy for stem cell differentiation. Biomaterials (2008) 1.17
Surface engineering of living myoblasts via selective periodate oxidation. Biotechnol Bioeng (2003) 1.13
Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source for great amounts of functional cardiomyocytes. Tissue Eng Part A (2008) 1.12
In vitro differentiation of mouse embryonic stem cells: enrichment of endodermal cells in the embryoid body. Stem Cells (2005) 1.05
Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies. Stem Cells Dev (2008) 1.02
Gene expression profiles during early differentiation of mouse embryonic stem cells. BMC Dev Biol (2009) 0.99
Scale-up of breast cancer stem cell aggregate cultures to suspension bioreactors. Biotechnol Prog (2006) 0.99
Cell-cell interaction modulates neuroectodermal specification of embryonic stem cells. Neurosci Lett (2008) 0.93
Improvement of culture conditions of human embryoid bodies using a controlled perfused and dialyzed bioreactor system. Tissue Eng Part C Methods (2008) 0.92
Size of the embryoid body influences chondrogenesis of mouse embryonic stem cells. J Tissue Eng Regen Med (2008) 0.91
Hypoxia-induced apoptosis in endothelial cells and embryonic stem cells. Apoptosis (2005) 0.89
Engineering embryonic stem-cell aggregation allows an enhanced osteogenic differentiation in vitro. Tissue Eng Part C Methods (2010) 0.86
Multi-well chip for forming a uniform embryoid body in a tiny droplet with mouse embryonic stem cells. Biosci Biotechnol Biochem (2007) 0.85
Vascular engineering using human embryonic stem cells. Biotechnol Prog (2009) 0.84
Monte Carlo simulation of LNCaP human prostate cancer cell aggregation in liquid-overlay culture. Biotechnol Prog (2003) 0.84
Embryonic stem cell sphere: a controlled method for production of mouse embryonic stem cell aggregates for differentiation. Int J Artif Organs (2008) 0.84
The method of mouse embryoid body establishment affects structure and developmental gene expression. Tissue Cell (2008) 0.83
Accelerated formation of multicellular 3-D structures by cell-to-cell cross-linking. Biotechnol Bioeng (2007) 0.83
A novel culture system shows that stem cells can be grown in 3D and under physiologic pulsatile conditions for tissue engineering of vascular grafts. J Surg Res (2006) 0.81
Dynamics of spheroid self-assembly in liquid-overlay culture of DU 145 human prostate cancer cells. Biotechnol Bioeng (2001) 0.81
Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol (2008) 3.14
CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets. Nat Immunol (2009) 3.00
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol (2005) 2.94
Selection of the cutaneous intraepithelial gammadelta+ T cell repertoire by a thymic stromal determinant. Nat Immunol (2006) 2.43
Early events in the thymus affect the balance of effector and regulatory T cells. Nature (2006) 1.78
The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer. J Exp Med (2003) 1.51
Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells. Stem Cells (2012) 1.49
Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc Natl Acad Sci U S A (2003) 1.48
Delivery of definable number of drug or growth factor loaded poly(DL-lactic acid-co-glycolic acid) microparticles within human embryonic stem cell derived aggregates. J Control Release (2013) 1.45
The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. Biomaterials (2009) 1.36
Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science (2012) 1.24
A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue. Mol Cell Biochem (2003) 1.18
Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineering. J Bone Miner Res (2003) 1.14
The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials (2009) 1.12
Controlled release of BMP-2 from a sintered polymer scaffold enhances bone repair in a mouse calvarial defect model. J Tissue Eng Regen Med (2012) 1.12
Tissue engineering: strategies, stem cells and scaffolds. J Anat (2008) 1.12
Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering. Adv Drug Deliv Rev (2007) 1.10
Dynamics of anterior-posterior axis formation in the developing mouse embryo. Nat Commun (2012) 1.08
Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization. Arterioscler Thromb Vasc Biol (2010) 1.07
Promotion of human dermal fibroblast migration, matrix remodelling and modification of fibroblast morphology within a novel 3D model by Lucilia sericata larval secretions. J Invest Dermatol (2006) 1.07
Attachment of stem cells to scaffold particles for intra-cerebral transplantation. Nat Protoc (2009) 1.04
Mathematical modelling of engineered tissue growth using a multiphase porous flow mixture theory. J Math Biol (2006) 1.02
Noninvasive detection and imaging of molecular markers in live cardiomyocytes derived from human embryonic stem cells. Biophys J (2011) 1.00
Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun (2002) 0.99
Probing the osteoinductive effect of calcium phosphate by using an in vitro biomimetic model. Tissue Eng Part A (2011) 0.98
Chemical modification of mammalian cell surfaces. Chem Soc Rev (2003) 0.98
Directed differentiation of human embryonic stem cells to interrogate the cardiac gene regulatory network. Mol Ther (2011) 0.97
Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles. Biomaterials (2012) 0.96
The effect of delivery via narrow-bore needles on mesenchymal cells. Regen Med (2009) 0.96
Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds. Tissue Eng (2004) 0.96
Plasticization and spraying of poly (DL-lactic acid) using supercritical carbon dioxide: control of particle size. J Pharm Sci (2004) 0.96
Molecular analysis of tumor-promoting CD8+ T cells in two-stage cutaneous chemical carcinogenesis. J Invest Dermatol (2009) 0.95
Mechanisms of ectopic bone formation by human osteoprogenitor cells on CaP biomaterial carriers. Biomaterials (2012) 0.95
In vitro assessment of cell penetration into porous hydroxyapatite scaffolds with a central aligned channel. Biomaterials (2004) 0.95
Immunoselection and adenoviral genetic modulation of human osteoprogenitors: in vivo bone formation on PLA scaffold. Biochem Biophys Res Commun (2002) 0.95
Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen (2005) 0.95
The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. Biomaterials (2008) 0.95
Maintenance of pluripotency in human embryonic stem cells cultured on a synthetic substrate in conditioned medium. Biotechnol Bioeng (2010) 0.94
Identification of a novel class of mammalian phosphoinositol-specific phospholipase C enzymes. Int J Mol Med (2005) 0.94
Scaffolds for liver tissue engineering. Expert Rev Med Devices (2006) 0.92
A novel technique for the production of electrospun scaffolds with tailored three-dimensional micro-patterns employing additive manufacturing. Biofabrication (2014) 0.91
Supercritical carbon dioxide: putting the fizz into biomaterials. Philos Trans A Math Phys Eng Sci (2006) 0.91
Control of pore size and structure of tissue engineering scaffolds produced by supercritical fluid processing. Eur Cell Mater (2007) 0.91
18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity. J Nucl Med (2013) 0.91
Scaffolds containing growth factors and extracellular matrix induce hepatocyte proliferation and cell migration in normal and regenerating rat liver. J Hepatol (2010) 0.90
The effect of processing variables on morphological and mechanical properties of supercritical CO2 foamed scaffolds for tissue engineering. Acta Biomater (2011) 0.90
The effect of three-dimensional co-culture of hepatocytes and hepatic stellate cells on key hepatocyte functions in vitro. Cells Tissues Organs (2005) 0.90
The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying. J Control Release (2005) 0.90
Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. Biomaterials (2012) 0.90
Three-Dimensional Bioactive and Biodegradable Scaffolds Fabricated by Surface-Selective Laser Sintering. Adv Mater (2004) 0.89
Biocompatibility and osteogenic potential of human fetal femur-derived cells on surface selective laser sintered scaffolds. Acta Biomater (2009) 0.88
Reconstruction of spatially orientated myotubes in vitro using electrospun, parallel microfibre arrays. Eur Cell Mater (2007) 0.88
Laminin and fibronectin treatment leads to generation of dendritic cells with superior endocytic capacity. PLoS One (2010) 0.88
Combined hydrogels that switch human pluripotent stem cells from self-renewal to differentiation. Proc Natl Acad Sci U S A (2014) 0.88
PLGA/PEG-hydrogel composite scaffolds with controllable mechanical properties. J Biomed Mater Res B Appl Biomater (2013) 0.87
Validation of a PicoGreen-based DNA quantification integrated in an RNA extraction method for two-dimensional and three-dimensional cell cultures. Tissue Eng Part C Methods (2012) 0.86
Gene therapy used for tissue engineering applications. J Pharm Pharmacol (2007) 0.86
Mapping calcium phosphate activated gene networks as a strategy for targeted osteoinduction of human progenitors. Biomaterials (2013) 0.86
Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1β, TNF-α, and IFN-γ. Stem Cells Dev (2014) 0.86
Engineering embryonic stem-cell aggregation allows an enhanced osteogenic differentiation in vitro. Tissue Eng Part C Methods (2010) 0.86
Cutaneous two-stage chemical carcinogenesis. CSH Protoc (2007) 0.86
A semi-autonomous model of endochondral ossification for developmental tissue engineering. Tissue Eng Part A (2012) 0.86
A thermoreversible hydrogel as a biosynthetic bandage for corneal wound repair. Biomaterials (2007) 0.85
Clinical applications of musculoskeletal tissue engineering. Br Med Bull (2008) 0.85
Mathematical modelling of tissue-engineered angiogenesis. Math Biosci (2009) 0.84
Mammalian cell survival and processing in supercritical CO(2). Proc Natl Acad Sci U S A (2006) 0.84
Aggregation promotes cell viability, proliferation, and differentiation in an in vitro model of injection cell therapy. J Tissue Eng Regen Med (2011) 0.84
Rapid micropatterning of cell lines and human pluripotent stem cells on elastomeric membranes. Biotechnol Bioeng (2012) 0.83
Accelerated formation of multicellular 3-D structures by cell-to-cell cross-linking. Biotechnol Bioeng (2007) 0.83
Development of a slow non-viral DNA release system from PDLLA scaffolds fabricated using a supercritical CO2 technique. Biotechnol Bioeng (2007) 0.83
Zonal release of proteins within tissue engineering scaffolds. J Mater Sci Mater Med (2006) 0.83
Alpha-MSH inhibits inflammatory signalling in Schwann cells. Neuroreport (2004) 0.82
Fluorescent oxygen sensitive microbead incorporation for measuring oxygen tension in cell aggregates. Biomaterials (2012) 0.81
Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix. PLoS One (2013) 0.81
Critical illness-related bone loss is associated with osteoclastic and angiogenic abnormalities. J Bone Miner Res (2012) 0.81
Label-free molecular imaging of immunological synapses between dendritic and T cells by Raman micro-spectroscopy. Analyst (2010) 0.81
Accelerating protein release from microparticles for regenerative medicine applications. Mater Sci Eng C Mater Biol Appl (2013) 0.81
The biology of equine mesenchymal stem cells: phenotypic characterization, cell surface markers and multilineage differentiation. Front Biosci (Landmark Ed) (2012) 0.81
Thermally triggered assembly of cationic graft copolymers containing 2-(2-methoxyethoxy)ethyl methacrylate side chains. Langmuir (2011) 0.80
Cell-type-specific adhesion onto polymer surfaces from mixed cell populations. Biotechnol Bioeng (2003) 0.80
Relating the chondrocyte gene network to growth plate morphology: from genes to phenotype. PLoS One (2012) 0.79
Spatial confinement of neurite regrowth from dorsal root ganglia within nonporous microconduits. Tissue Eng (2003) 0.79
The Intercostal NMJ Assay: a new alternative to the conventional LD50 assay for the determination of the therapeutic potency of botulinum toxin preparations. Altern Lab Anim (2008) 0.79
An automated fabrication strategy to create patterned tubular architectures at cell and tissue scales. Biofabrication (2015) 0.78
Encapsulation of RIN-m5F cells within Ba2+ cross-linked alginate beads affects proliferation and insulin secretion. J Microencapsul (2006) 0.78
The application of human bone marrow stromal cells and poly(dl-lactic acid) as a biological bone graft extender in impaction bone grafting. Biomaterials (2008) 0.78
Biocompatibility and enhanced osteogenic differentiation of human mesenchymal stem cells in response to surface engineered poly(D,L-lactic-co-glycolic acid) microparticles. J Biomed Mater Res A (2013) 0.78
Gelation of microsphere dispersions using a thermally-responsive graft polymer. J Colloid Interface Sci (2013) 0.78
The scale-up of a tissue engineered porous hydroxyapatite polymer composite scaffold for use in bone repair: an ovine femoral condyle defect study. J Biomed Mater Res A (2014) 0.78
In situ gelling hydrogels incorporating microparticles as drug delivery carriers for regenerative medicine. J Pharm Sci (2008) 0.78
Sox9 reprogrammed dermal fibroblasts undergo hypertrophic differentiation in vitro and trigger endochondral ossification in vivo. Cell Reprogram (2014) 0.77
Development of a bioluminescent ATP assay to quantify mammalian and bacterial cell number from a mixed population. Biomaterials (2003) 0.77
Image-based characterization of foamed polymeric tissue scaffolds. Biomed Mater (2008) 0.77
Ultrasonic monitoring of foamed polymeric tissue scaffold fabrication. J Mater Sci Mater Med (2008) 0.77